Therapeutic Specialties Archives

Conference

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

We’re excited to participate in JSCPT 2025 in Tokyo, The 46th Annual Scientific Meeting of…

CertaraOctober 31, 2024

Blog

Mathematical Models can Assist in Broadening use of Immuno-oncology Drugs to Treat Autoimmunity

Connecting Cancer and Autoimmunity "The dosing regimens in oncology may not directly inform the optimal…

CertaraOctober 31, 2024

On-Demand Webinar

RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview

Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…

CertaraOctober 17, 2024

On-Demand Webinar

Quantitative Systems Pharmacology (QSP) Enabled First-in-Human Study in Oncology

CertaraSeptember 16, 2024

On-Demand Webinar

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…

CertaraAugust 19, 2024

Case Study

Optimizing Clinical Development: Saving Time and Costs

Strategic mechanistic modeling solutions help an immunoncology biotech accelerate their clinical development of novel therapeutics.

CertaraAugust 16, 2024

Case Study

Medicines that matter: Biohaven’s Nurtec™ drug development journey

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…

CertaraAugust 15, 2024

Case Study

Model-Informed Confidence in Oncology Dose Selection

Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…

CertaraAugust 9, 2024

Video

Certara’s MIDD Oncology Capabilities

Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…

CertaraAugust 7, 2024

Publication

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

CertaraJuly 23, 2024

Therapeutic Specialties

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

Mathematical Models can Assist in Broadening use of Immuno-oncology Drugs to Treat Autoimmunity

RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview

Quantitative Systems Pharmacology (QSP) Enabled First-in-Human Study in Oncology

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

Optimizing Clinical Development: Saving Time and Costs

Medicines that matter: Biohaven’s Nurtec™ drug development journey

Model-Informed Confidence in Oncology Dose Selection

Certara’s MIDD Oncology Capabilities

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Newsletter sign up

Quick links

Solutions

Contact